Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction

咽喉反流 医学 回流 病史 家族史 疾病 内科学 儿科
作者
Marie Mailly,Robin Baudouin,Camille Thibault,Stéphane Hans,Jérôme R. Lechien
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
标识
DOI:10.1001/jamaoto.2024.5046
摘要

Importance Retrograde cricopharyngeus dysfunction (R-CPD) is an emerging disorder associated with disabling symptoms. The origin of R-CPD remains unknown. Objective To investigate the development of symptoms, diagnosis approach, and therapeutic outcomes of R-CPD in patients treated with in-office botulinum toxin injection (BTI) into the cricopharyngeus. Design, Setting, and Participants This was a case series including patients with R-CPD who were consecutively and prospectively recruited from April 2022 to May 2024 in an academic hospital. Semistructured interviews were conducted to collect and analyze data on each patient’s clinical history, potential causes or factors associated with R-CPD development, diagnostic approaches, and symptom presentation. Intervention Clinic-based (in-office) BTI into the cricopharyngeus. Outcomes and Measures Associations with laryngopharyngeal reflux disease, patients’ Reflux Symptom Score-12 (RSS-12), and BTI effectiveness, revisions, and complications were evaluated. Results The case series comprised 106 patients with R-CPD treated with BTI (52 females [49.1%] and 54 males [51.9%]). Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years. Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents’ testimonies. A family history was reported in 18 of 62 cases (29.0%). In 105 cases (99.1%), patients made the diagnosis themselves despite medical consultations (n = 162), empirical treatments (n = 113), and additional examinations (n = 92). The cumulative success rate of BTI was 90.6% (96 of 106 patients). In 26 cases (24.5%), additional injections were administered to address the symptoms. Family history of R-CPD was a negative predictor of single-BTI success. Dysphagia was the primary adverse effect occurring after 89 of 126 BTIs (70.6%) and lasted a mean (SD) of 16.3 (12.0) days. In 10 cases, operating-room BTI was administered after primary in-office BTI. Conclusions and Relevance R-CPD is an emerging and poorly known disorder associated with high rates of ineffective consultations, additional examinations, and self-diagnosis by patients. In-office BTI was associated with a high rate of partial or total symptom relief and long-term effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer应助11采纳,获得10
刚刚
牛马完成签到,获得积分10
1秒前
runner完成签到,获得积分10
1秒前
jimmyC完成签到,获得积分10
1秒前
云儿完成签到,获得积分10
1秒前
顾矜应助mamahaha采纳,获得10
2秒前
2秒前
123发布了新的文献求助10
2秒前
3秒前
虚幻采枫完成签到,获得积分10
3秒前
0411345完成签到,获得积分10
4秒前
5秒前
5秒前
xigua应助卢莹采纳,获得10
5秒前
桐桐应助卢莹采纳,获得10
5秒前
善学以致用应助谦让元蝶采纳,获得10
6秒前
6秒前
沉默的茉莉完成签到 ,获得积分10
6秒前
6秒前
不想长大发布了新的文献求助10
6秒前
6秒前
7秒前
华西招生版完成签到,获得积分10
7秒前
打打应助MR_Z采纳,获得10
7秒前
所所应助时尚俊驰采纳,获得10
8秒前
8秒前
翎儿响叮当完成签到 ,获得积分10
9秒前
10秒前
汉堡包应助111222采纳,获得10
10秒前
10秒前
Hello应助科研通管家采纳,获得10
10秒前
wu8577应助科研通管家采纳,获得10
10秒前
10秒前
怎么说应助科研通管家采纳,获得10
10秒前
科目三应助科研通管家采纳,获得10
10秒前
10秒前
所所应助科研通管家采纳,获得30
11秒前
星辰大海应助科研通管家采纳,获得10
11秒前
Jasper应助科研通管家采纳,获得10
11秒前
脑洞疼应助科研通管家采纳,获得10
11秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
不知道标题是什么 500
Christian Women in Chinese Society: The Anglican Story 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961675
求助须知:如何正确求助?哪些是违规求助? 3507998
关于积分的说明 11139238
捐赠科研通 3240579
什么是DOI,文献DOI怎么找? 1791017
邀请新用户注册赠送积分活动 872696
科研通“疑难数据库(出版商)”最低求助积分说明 803326